Vicuron Holdings Drug Patent Portfolio
Vicuron Holdings owns 1 orange book drug protected by 3 US patents Given below is the list of Vicuron Holdings's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6960564 | Echinocandin pharmaceutical formulations containing micelle-forming surfactants | 12 Apr, 2021 | Expired |
| US7709444 | Echinocandin pharmaceutical formulations containing micelle-forming surfactants | 12 Apr, 2021 | Expired |
| US5965525 | Cyclic peptide antifungal agents | 17 Feb, 2020 | Expired |
Latest Legal Activities on Vicuron Holdings's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Vicuron Holdings.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 06 Jun, 2022 | US7709444 |
|
Maintenance Fee Reminder Mailed
Critical
| 20 Dec, 2021 | US7709444 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 16 Oct, 2017 | US7709444 |
|
Correspondence Address Change
Critical
| 23 Aug, 2010 | US7709444 |
| Post Issue Communication - Certificate of Correction | 10 Aug, 2010 | US7709444 |
|
Email Notification
Critical
| 27 Jul, 2010 | US7709444 |
| Mail-Record a Petition Decision of Granted to Issue Patent in Name of the Assignee | 20 Jul, 2010 | US7709444 |
| Record a Petition Decision of Granted to Issue Patent in Name of the Assignee | 19 Jul, 2010 | US7709444 |
| Petition Entered | 14 Jun, 2010 | US7709444 |
| Post Issue Communication - Certificate of Correction Denied | 16 May, 2010 | US7709444 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 04 May, 2010 | US7709444 |
|
Recordation of Patent Grant Mailed
Critical
| 04 May, 2010 | US7709444 |
|
Email Notification
Critical
| 15 Apr, 2010 | US7709444 |
|
Issue Notification Mailed
Critical
| 14 Apr, 2010 | US7709444 |
| Dispatch to FDC | 24 Mar, 2010 | US7709444 |
Vicuron Holdings's Family Patents
Vicuron Holdings Drug List
Given below is the complete list of Vicuron Holdings's drugs and the patents protecting them.
1. Eraxis
Eraxis is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6960564 | Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
12 Apr, 2021
(3 years ago)
| Expired |
| US7709444 | Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
12 Apr, 2021
(3 years ago)
| Expired |
| US5965525 | Cyclic peptide antifungal agents |
17 Feb, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Eraxis's drug page